Objective: To compare the efficacy of fresh frozen plasma (FFP) with cryopoor plasma (CPP) to treat vitamin K–dependent factor deficiency in a canine in vitro setting. Design: In vitro laboratory study. Setting: University veterinary medical teaching hospital. Animals: Seven units of FFP and 6 units of CPP from unique canine donors from the university veterinary blood bank. Interventions: Canine FFP was adsorbed by oral barium sulfate suspension to mimic vitamin K–dependent coagulopathy. A sequential mixing study was completed by adding FPP or CPP to the adsorbed plasma. Measurements of prothrombin time (PT), activated partial thromboplastin time (aPTT), fibrinogen, and factor activities of factors II, VII, and IX (FII, FVII, and FIX) were compared between the 2 treatment groups. Measurements and main results: When comparing the sequential addition of CPP or FPP to adsorbed plasma, the following had no statistical significance: PT (P = 0.94), aPTT (P = 0.66), FII (P = 0.05), and FIX (P = 0.90). There was a dose-dependent decrease with PT and aPTT and a dose-dependent increase with FII and FIX. In contrast, after the addition of either CPP or FFP, there was a significant difference between the treatment groups for the concentration of fibrinogen (P = 0.005) and activity of FVII (P = 0.044), with FFP resulting in a greater concentration of fibrinogen and CPP resulting in a greater concentration of FVII. Measurements of factor X (FX) were initially included in the study but were later excluded because FX appeared to be continually adsorbed even after the addition of CPP or FFP. Conclusions: CPP partially corrected the coagulation times and concentration of vitamin K–dependent coagulation factors to the same degree as FFP. CPP, generally less expensive than FFP, may provide an alternative treatment option for vitamin K–dependent coagulopathies, although in vivo testing is needed.
- fresh frozen plasma
ASJC Scopus subject areas